Corcept Therapeutics
CORT
CORT
190 hedge funds and large institutions have $1.61B invested in Corcept Therapeutics in 2017 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 75 increasing their positions, 50 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
190
Holders Change
+1
Holders Change %
+0.53%
% of All Funds
4.32%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.11%
New
43
Increased
75
Reduced
50
Closed
42
Calls
$11.5M
Puts
$8.91M
Net Calls
+$2.55M
Net Calls Change
-$4.24M
Top Buyers
| 1 |
1
BlackRock
New York
|
$206M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$169M |
| 3 |
CCM
3
Consonance Capital Management
New York
|
$104M |
| 4 |
4
Renaissance Technologies
New York
|
$89.5M |
| 5 |
5
State Street
Boston,
Massachusetts
|
$51.9M |
